<Daily Summary> HSI Ends at 25,498, Gaining 29 Points; HSTI Finishes at 5,418, Dropping 39 Points; CSPC PHARMA Surges Over 6%; HSBC HOLDINGS, CHINA EAST AIR, CHINA SOUTH AIR, AIR CHINA Reach New Peaks; Market Turnover Increases | Intellectia.AI
<Daily Summary> HSI Ends at 25,498, Gaining 29 Points; HSTI Finishes at 5,418, Dropping 39 Points; CSPC PHARMA Surges Over 6%; HSBC HOLDINGS, CHINA EAST AIR, CHINA SOUTH AIR, AIR CHINA Reach New Peaks; Market Turnover Increases
Written by Emily J. Thompson, Senior Investment Analyst
Market Performance: The Hang Seng Index (HSI) rose by 29 points (0.1%) to close at 25,498, while the Hang Seng Technology Index (HSTI) fell by 39 points (0.7%) to 5,418, and the Hang Seng China Enterprises Index (HSCEI) decreased by 2 points (0.0%) to 8,841, with a total market turnover of $162.38 billion.
Active Heavyweights: Notable movements included Xiaomi down 2.5% to $40.2, Alibaba down 1.3% to $144.1, and CCB up 1.2% to $7.52. HKEX and Meituan also saw slight increases, while Tencent remained unchanged.
Top Gainers and Losers: CSPC Pharma surged 6.5% to $8.01, Sinopec Corp rose 3.4% to $4.6, and HSBC Holdings increased by 1% to $118.7, reaching a new high. Conversely, CaoCao Inc dropped 12.3% to $28.96, and Yixin fell 10.7% to $2.58.
Airline Stocks Performance: China Eastern Airlines and China Southern Airlines saw significant gains, with increases of 8.1% and 5.6% respectively, while Air China rose 4.8%, all reaching new highs.
Wall Street analysts forecast 00005 stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for 00005 is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
0 Analyst Rating
Wall Street analysts forecast 00005 stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for 00005 is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
0 Buy
0 Hold
0 Sell
Current: 127.000
Low
Averages
High
Current: 127.000
Low
Averages
High
DBS
maintain
$139.2
Al Analysis
2026-01-09
Reason
DBS
Price Target
$139.2
Al Analysis
2026-01-09
maintain
Reason
The analyst rating from UBS for HSBC HOLDINGS (00005.HK) is maintained at Neutral with a target price of GBP10.35. The reason for this rating is that while UBS is more positive on the privatization deal involving Hang Seng Bank, they did not alter the ultimate value of HSBC HOLDINGS. This suggests that UBS sees potential benefits from the transaction but does not expect it to significantly change the overall valuation of HSBC in the long term.
Citi Research
NULL
to
Buy
maintain
2026-01-09
Reason
Citi Research
Price Target
2026-01-09
maintain
NULL
to
Buy
Reason
The analyst rating from Citi Research for HSBC HOLDINGS is based on several key factors:
1. Lowered EPS Forecasts: Citi Research has slightly reduced its EPS forecasts for 2025-2027 by 0-1%, primarily due to the expectation of an additional Federal Reserve rate cut in 2026.
2. Higher Revenue Assumptions: Despite the slight decline in EPS forecasts, Citi's projections remain 2-9% higher than the latest market consensus for the company's profit before tax. This is attributed to expectations of strong revenue growth, particularly in non-interest income from the Asian wealth business.
3. Positive Return on Tangible Equity (RoTE): Citi believes that HSBC can achieve a RoTE of approximately 19-20% in 2027-2028, indicating strong profitability potential.
4. Increased Target Price: With the introduction of a 2028 forecast and an extended terminal year in its valuation model, Citi raised its target price for HSBC from $127.8 to $138.3.
5. Reiterated Buy Rating: Given these factors, Citi Research has maintained a "Buy" rating on HSBC HOLDINGS, reflecting confidence in the company's future performance despite the minor adjustments to EPS forecasts.
Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for 00005
Unlock Now
Citi
maintain
$138.3
2026-01-09
Reason
Citi
Price Target
$138.3
2026-01-09
maintain
Reason
The analyst rating from UBS is maintained as Neutral for HSBC Holdings (HSBA.L) with a target price of GBP10.35. The reason for this rating is that while UBS is more positive on the privatization deal involving Hang Seng Bank than the market, it did not alter the ultimate value of HSBC Holdings. This suggests that UBS sees potential benefits from the transaction but does not believe it significantly changes the overall valuation of HSBC.
Citi
NULL
to
Buy
maintain
2026-01-09
Reason
Citi
Price Target
2026-01-09
maintain
NULL
to
Buy
Reason
Citi has lowered its 2025-27 EPS estimates for HSBC HOLDINGS by 0-1% due to considerations regarding the Federal Reserve's interest rate cut forecasts. Despite this adjustment, the broker maintains a positive outlook, believing that HSBC HOLDINGS can achieve a return on tangible equity (RoTE) of around 19-20% by 2027 to 2028. Consequently, Citi has reiterated a Buy rating on HSBC HOLDINGS and raised its target price from HKD 127.8 to HKD 138.3.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
